325
Views
3
CrossRef citations to date
0
Altmetric
Drug Evaluation

The potential role of elagolix for treating uterine bleeding associated to uterine myomas

ORCID Icon, ORCID Icon, , , , & ORCID Icon show all
Pages 1419-1430 | Received 16 Aug 2019, Accepted 09 Apr 2020, Published online: 13 May 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Susan Dababou, Simone Garzon, Antonio Simone Laganà, Simone Ferrero, Giulio Evangelisti, Marco Noventa, Maurizio Nicola D’Alterio, Stefano Palomba, Stefano Uccella, Massimo Franchi & Fabio Barra. (2021) Linzagolix: a new GnRH-antagonist under investigation for the treatment of endometriosis and uterine myomas. Expert Opinion on Investigational Drugs 30:9, pages 903-911.
Read now
Mohamed Ali, Sara A.R.Ayman Al Hendy. (2021) Elagolix in the treatment of heavy menstrual bleeding associated with uterine fibroids in premenopausal women. Expert Review of Clinical Pharmacology 14:4, pages 427-437.
Read now

Articles from other publishers (1)

Juliawati Muhammad, Yusnita Yusof, Imran Ahmad & Mohd Noor Norhayati. (2022) Elagolix treatment in women with heavy menstrual bleeding associated with uterine fibroid: a systematic review and meta-analysis. BMC Women's Health 22:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.